Dove Medical Press podcasts
By Dove Medical Press
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Dove Medical Press
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 33
Description
Welcome to the Dove Medical Press podcast series where hot topics in the world of medical research are discussed by those who know it best.
| Episode | Date |
|---|---|
|
Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments
|
Jul 02, 2025 |
|
Advancing AML Treatment: Evidence-Based Regimens and Guideline Updates for Targeted Treatments in R/R AML
|
Jul 02, 2025 |
|
Unveiling the Mysteries of Molecular Testing in AML: A Guide for Oncologists
|
Jun 22, 2025 |
|
Exploring the Chronic Nature of Generalized Pustular Psoriasis
|
Feb 03, 2025 |
|
Exploring the clinical presentation, course, and burden of disease in generalized pustular psoriasis
|
Feb 28, 2024 |
|
Exploring the quality-of-life impact, disease burden, and management challenges of GPP: the provider and patient perspective
|
Nov 16, 2023 |
|
Biosimilars for Rheumatoid Arthritis Riding the 2023 Wave
|
Oct 30, 2023 |
|
Exploring the clinical assessment, guidelines, and options for the treatment of generalized pustular psoriasis
|
Oct 25, 2023 |
|
Exploring the Clinical Features, Immunopathogenesis and Approach to Diagnosis for Generalized Pustular Psoriasis
|
Jun 20, 2023 |
|
A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 2: Negative Symptoms in Schizophrenia
|
May 31, 2023 |
|
A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 1: Addressing Daily Functioning and Cognitive Impairments Associated with Schizophrenia
|
May 31, 2023 |
|
The role of active smoking in the management of COPD
|
Nov 28, 2022 |
|
The lung microbiome and ICS: Influence of airway inflammation on COPD treatment
|
Oct 25, 2022 |
|
Comorbidities in COPD: Cardiovascular crossover
|
Aug 21, 2022 |
|
Low-and middle-income countries: Their influence on global COPD guidelines
|
Aug 09, 2022 |
|
Understanding inspiratory effort in COPD management
|
Jul 26, 2022 |
|
Real-world studies in COPD: What does the evidence say?
|
Jul 12, 2022 |
|
Optimising care in COPD: managing co-existent bronchiectasis
|
Jun 29, 2022 |
|
The role of imaging in early COPD management
|
Jun 07, 2022 |
|
Beating breathlessness: The impact of dyspnoea in COPD
|
May 24, 2022 |
|
Elevating the use of inhalers: Adherence in COPD
|
May 10, 2022 |
|
The impact of triple therapy: Mortality in COPD
|
Apr 25, 2022 |
|
The management of early COPD - thinking out of the box
|
Apr 05, 2022 |
|
The importance of study design: The KEY to interpreting COPD research
|
Mar 22, 2022 |
|
Phenotyping in COPD: Tailoring treatment to each patient
|
Mar 08, 2022 |
|
COPD and comorbidities: How can epidemiology help us?
|
Feb 22, 2022 |
|
Treating patients with COPD: When should we use ICS?
|
Feb 08, 2022 |
|
Macrolides in COPD: Targeting airway inflammation
|
Jan 30, 2022 |
|
Managing COPD patients during the COVID-19 pandemic
|
Dec 31, 2021 |
|
Inhalation effort for COPD patients and why inhaler choice matters
|
Dec 23, 2021 |
|
ATS guidelines in COPD: When is one therapy not enough?
|
Dec 15, 2021 |
|
Is two better than one? Early optimisation with dual bronchodilation in COPD
|
Nov 30, 2021 |
|
The use of ICS in COPD: Discussing new European Respiratory Society Guidelines
|
Nov 10, 2021 |